Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer risk

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 757-761

  Jiang, Zongdan ^a   Zhang, Zhenyu ^a   Wang, Zhibing ^a   Zhang, Gongyu ^a   Hu, Kewei ^a   He, Bangshun ^b   Wang, Shukui ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Gene polymorphism; Myeloperoxidase

Indexed keywords

IMMUNOGLOBULIN G; MYELOPEROXIDASE;

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; GROUPS BY AGE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MPO GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; STOMACH CANCER;

AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEROXIDASE; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84860532318     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11054     Document Type: Article

References (42)

1. Wu MS, Chen CJ, Lin JT: Host-environment interactions: their impact on progression from gastric in. ammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidem Biomar 2005; 14:1878-1882.
2. Roberts-Thomson IC, Butler WJ: Polymorphism and gastric cancer. J Gastroenterol Hepatol 2005; 20:793-794. (Pubitemid 40733381)
3. Ohnishi S, Murata M, Kawanishi S: DNA damage induced by hypochlorite and hypobromite with reference to inflammation-associated carcinogenesis. Cancer Lett 2002; 178:37-42. (Pubitemid 34159239)
4. Whiteman M, Spencer JP, Jenner A, et al.: Hypochlorous acid-induced DNA base modification: potentiation by nitrite: biomarkers of DNA damage by reactive oxygen species. Biochem Bioph Res Co 1999; 257:572-576. (Pubitemid 29301484)
5. Lin SC, Chou YC, Wu MH, et al.: Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur J Cancer Prev 2005; 14:257-261.
6. Ahn J, Gammon MD, Santella RM, et al.: Myeloperoxidase genotype, fruit and vegetable consumption and breast cancer risk. Cancer Res 2004; 64:7634-7639. (Pubitemid 39372111)
7. Matsuo K, Hamajima N, Shinoda M, et al.: Possible risk reduction in esophageal cancer associated with MPO-463 A allele. J Epidemiol 2001; 11:109-114. (Pubitemid 33798354)
8. Hung RJ, Boffetta P, Brennan P, et al.: Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004; 25:973-978. (Pubitemid 38886083)
9. Matsuo K, Hamajima N, Suzuki R, et al.: No substantial difference in geno-type frequencies of interleukin and myeloperoxidase polymorphisms between malignant lymphoma patients and non-cancer controls. Haematologica 2001; 86:602-608. (Pubitemid 32601103)
10. Pakakasama S, Chen TT, Frawley W, et al.: Myeloperoxidase promotor polymorphism and risk of hepatoblastoma. Int J Cancer 2003; 106:205-207. (Pubitemid 36835172)
11. Cascorbi I, Henning S, Brockmoller J, et al.: Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463→A of the myeloperoxidase gene. Cancer Res 2000; 60:644-649. (Pubitemid 30094562)
12. Roe I, Nam S, Kim J, et al.: Association of the myeloperoxidase-463G-A polymorphism with development of atrophy in Helicobacter pylori-infected gastritis. Am J Gastroenterol 2002; 97:1629-1634. (Pubitemid 34761381)
13. Zhu H, Yang L, Zhou B, et al.: Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis 2006; 27:2491-2496. (Pubitemid 44884108)
14. Verdecchia A, Corazziari I, Gatta G, et al.: Explaining gastric cancer survival differences among European countries. Int J Cancer 2004; 109:737-741. (Pubitemid 38405622)
15. Hamilton JP, Meltzer SJ: A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol 2006; 4:416-425.
16. Boccia S, Gianfagna F, La Torre G, et al.: Genetic Susceptibility to Gastric Cancer: A review of the Published Meta-Analyses. In Cardinni, D.C. (ed.), Research Focus on Gastric Cancer. Hauppauge, NY: Nova Science Publishers 2008; 137-163.
17. International Human Genome Sequencing Consortium: Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
18. Hazen SL, Hsu FF, Mueller DM, et al.: Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 1996; 98:1283-1289. (Pubitemid 26322052)
19. Hurst JK, Albrich JM, Green TR, et al.: Myeloperoxidase-dependent fluorescein chlorination by stimulated neutrophils. J Biol Chem 1984; 259:4812-4821. (Pubitemid 14144200)
20. Suzuki H, Seto K, Mori M, et al: Monochloramine induced DNA fragmentation in gastric cell line MKN45. Am J Physiol 1998; 275:G712-G716.
21. Petruska JM, Mosebrook R, Jakab GJ, et al.: Myeloperoxidase-enhanced formation of (±)-trans-7,8-dihydroxy-7,8dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 1992; 13:1075-1081.
22. Mallet WG, Mosebrook DR, Trush MA: Activation of (±)-trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear lenkocytes or myeloperoxidase. Carcinogenesis 1991; 12: 521-524.
23. Feyler A, Voho A, Bouchardy C, et al.: Point: myeloperoxidase-463G-A polymorphism and lung cancer risk. Cancer Epidem Biomar 2002; 11:1550-1554. (Pubitemid 36020005)
24. Schabath MB, Spitz MR Zhang X, et al.: Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 2000; 21:1163-1166. (Pubitemid 30389342)
25. Xu LL, Liu G Miller DP, et al.: Counterpoint: myeloperoxidase463GA polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidem Biomar 2002; 11:1555-1559. (Pubitemid 36020006)
26. Cascorbi I, Henning S, Brockmoller J, et al.: Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res 2000; 60:614-649.
27. Skuladottir H, Autrup H, Autrup J, et al.: Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung Cancer 2005; 48:187-199.
28. Lu W, Xing D, Qi J, et al.: Genetic polymorphism in myeloperoxidase but not GSTMl is associated with risk of lung squamous cell carcinoma in a Chinese population. Int J Cancer 2002; 102:275-279. (Pubitemid 35222299)
29. Chan EC, Lam SY, Fu KH, et al: Polymorphisms of the GSTMl, GSTP1, MPO, XRCCl and NQOI genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Gen Cytogen 2005; 162:10-20. (Pubitemid 41278465)
30. Le Marchand L, Seifried A, Lum A, et al.: Association of the myeloperoxidase -463G→A polymorphism with lung cancer risk. Cancer Epidem Biomar 2000; 9:18l-184.
31. Misra RR, Tangrea JA, Virtamo J, et al.: Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett 2001; 164:161-167. (Pubitemid 32155504)
32. London SJ, Lehman TA, Taylor JA: Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997; 57:50015003.
33. Liu G, Zhou W, Wang Li, et al.: MPO and SOD2 polymorphisms, gender and the risk of non-small cell lung carcinoma. Cancer Lett 2004; 214:69-79. (Pubitemid 39141200)
34. Lin SC, Chou YC, Wu MH, et al.: Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur J Cancer Prev 2005; 14:257-261.
35. Ahn J, Gammon MD, Santella RM, et al.: Myeloperoxidase genotype, fruit and vegetable consumption and breast cancer risk. Cancer Res 2004; 64:7634-7639. (Pubitemid 39372111)
36. Olson SH, Carlson MD, Ostrer H, et al.: Genetic variants in SOD2, MPO and NQO1 and risk of ovarian cancer. Gynecol Oncol 2004; 93:615-620. (Pubitemid 38766044)
37. Schabath M.B, Spitz MR, Zhang X, et al.: Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 2000; 21:1163-1166. (Pubitemid 30389342)
38. Chan EC, Lam SY, Fu KH, Kwong YL: Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Gen Cytogen 2005; 162:10-20. (Pubitemid 41278465)
39. Reynolds WF, Hiltunen M, Pirskanen M, et al.: MPO and APOE epsilon 4 polymorphisms interact to increase risk for AD in Finnish males. Neurology 2000; 55:1284-1290.
40. Hamajima N, Matsuo K, Suzuki T, et al.: Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn J Cancer Res 2001; 92:488-493. (Pubitemid 32515088)
41. Lu W, Xing D, Qi J, Tan W, Miao X, Lin D: Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population. Int J Cancer 2002; 102:275-279. (Pubitemid 35222299)
42. Feyler A, Voho A, Bouchardy C, et al.: Point: myeloperoxidase463Gà A polymorphism and lung cancer risk. Cancer Epidem Biomar 2002; 11:1550-1554. (Pubitemid 36020005)